CEACAM5 and malignant colon neoplasm: Chen et al. [40] also reported that serum pGSN levels were significantly lower in patients with colon cancer than in healthy controls and that pGSN could serve as a more effective diagnostic biomarker for colon cancer compared with the currently used carcinoembryonic antigen.